Acotec Scientific Holdings Limited (HKG:6669)
13.59
+1.29 (10.49%)
Sep 5, 2025, 4:08 PM HKT
HKG:6669 Revenue
Acotec Scientific Holdings had revenue of 351.20M CNY in the half year ending June 30, 2025, with 44.49% growth. This brings the company's revenue in the last twelve months to 592.85M, up 13.33% year-over-year. In the year 2024, Acotec Scientific Holdings had annual revenue of 533.99M with 12.69% growth.
Revenue (ttm)
592.85M CNY
Revenue Growth
+13.33%
P/S Ratio
6.56
Revenue / Employee
912.08K CNY
Employees
650
Market Cap
4.26B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 533.99M | 60.14M | 12.69% |
Dec 31, 2023 | 473.85M | 78.30M | 19.80% |
Dec 31, 2022 | 395.55M | 91.73M | 30.19% |
Dec 31, 2021 | 303.81M | 109.84M | 56.62% |
Dec 31, 2020 | 193.98M | 69.07M | 55.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
WuXi Biologics | 21.98B |
Akeso | 2.75B |
CSPC Pharmaceutical Group | 28.49B |